Stock Markets Analysis & Opinion

Facebook, Inc. (NASDAQ:FB) is set to report fourth-quarter 2017 results on Jan 31. We believe the company’s strength in online and mobile advertising revenues, coupled with expanding Instagram...

AVANGRID, Inc.’s (NYSE:AGR) subsidiary, Avangrid Renewables, announced that it has signed a power purchase agreement (PPA) regarding a second wind contract with Nike, Inc. (NYSE:NKE) .The...

Regency Centers Corporation (NYSE:REG) recently announced the acquisition of two adjacent properties in Long Island, NY. The off-market buyout helps the company boost its portfolio with a property...

AVANGRID, Inc.'s (NYSE:AGR) subsidiary, Avangrid Renewables, announced that it has begun commercial operations of three new wind farms. The unit began the operation of Tule Wind Farm with generation...

Carnival (LON:CCL) Corporation (NYSE:CCL) recently announced that one of its Ocean Originals TV programs, The Voyager with Josh Garcia, will be distributed on Telemundo, an American Spanish-language...

Qualcomm Inc. (NASDAQ:QCOM) recently signed a memorandum of understanding with four leading Chinese handset developers, namely, Lenovo Mobile Communication Technology, Ltd., Guangdong OPPO Mobile...

HCA Healthcare, Inc. (NYSE:HCA) has been witnessing consistent growth in its revenue base. In the past five years, revenues have recorded a compound annual growth rate of nearly 7% on the back of...

Korean steel producer POSCO (NYSE:PKX) reported impressive results for 2017. Net income increased 183.8% year over year to KRW 2,974 billion ($2.6 billion) driven primarily by increase in operating...

German vehicle manufacturers, Daimler AG (DE:DAIGn) (OTC:DDAIF) and BMW AG BAMXF, are working toward combining their car-sharing services, per a Reuters report. The merger talks between the Car2Go...

North Chicago, IL-based AbbVie Inc. (NYSE:ABBV) is best known for its autoimmune disease drug, Humira. AbbVie’s flagship product Humira is approved for several indications like rheumatoid...

Seattle Genetics, Inc. (NASDAQ:SGEN) is a biopharmaceutical company focused on the development and commercialization of therapies targeted for the treatment of cancer. The company has only one...

There are plenty of choices in the Non US - Equity category, but where should you start your research? Well, one fund that might be worth investigating is T. Rowe Price Emerging Markets Stock PRMSX....

If you have been looking for Global - Equity funds, a place to start could be Oppenheimer Global Opportunities Y OGIYX. OGIYX has a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on nine...

QIAGEN's (NYSE:QGEN) ipsogen JAK2 RGQ PCR Kit (ipsogen JAK2 assay) received FDA approval for additional use in the diagnosis of all myeloproliferative neoplasms (MPNs). In this cancer group, blood...